NCT00256919 - Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions

Arthritis, Rheumatoid

Interventions

DRUG

GW856553

Trial Locations (17)

1233

GSK Investigational Site, Sofia

1431

GSK Investigational Site, Sofia

4000

GSK Investigational Site, Plovdiv

15706

GSK Investigational Site, Santiago de Compostela

21075

GSK Investigational Site, Hamburg

24576

GSK Investigational Site, Bad Bramstedt

28046

GSK Investigational Site, Madrid

41071

GSK Investigational Site, Seville

61002

GSK Investigational Site, Kharkiv

79010

GSK Investigational Site, Lviv

80639

GSK Investigational Site, Munich

83045

GSK Investigational Site, Donetsk

91056

GSK Investigational Site, Erlangen

SE-582 25

GSK Investigational Site, Linköping

SE-753 23

GSK Investigational Site, Uppsala

01030

GSK Investigational Site, Kiev

03680

GSK Investigational Site, Kyiv